31 Results

People

  1. Park
    Park
  2. Tallman
    Tallman
  3. Brentjens
    Brentjens
  4. Riviere
    Riviere
  5. Sadelain
    Sadelain
  6. Devlin
    Devlin
  7. Geyer
    Geyer
  8. Perales
    Perales
  9. Wang
    Wang
  10. Sauter
    Sauter

Groups

  1. Adult Leukemia (31)
  2. Center for Hematologic Malignancies (31)
  3. Department of Medicine (31)
  4. Hematologic Malignancies, Division of (31)
  5. GSK Faculty (14)
  6. Epidemiology and Biostatistics (13)
  7. Biostatistics Service (12)
  8. Molecular Pharmacology and Chemistry Program Faculty (11)
  9. Sloan Kettering Institute Faculty (11)
  10. Hematologic Malignancies Research (10)
  1. "adult"
  2. "Jae Park"
Formats
  1. Journal Article (28)
  2. Correspondence (1)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Adult Leukemia (31)
  2. Center for Hematologic Malignancies (31)
  3. Department of Medicine (31)
  4. Hematologic Malignancies, Division of (31)
  5. GSK Faculty (14)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Jae Park (31)
  2. Martin Tallman (11)
  3. Isabelle Riviere (9)
  4. Michel Sadelain (9)
  5. Renier Brentjens (9)
  6. Sean Devlin (7)

More People

Years
  1. 2023 (7)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (4)
  5. 2019 (3)
  6. 2018 (4)

More Years

Publications
  1. Blood (5)
  2. Leukemia and Lymphoma (4)
  3. American Journal of Hematology (2)
  4. Blood Advances (2)
  5. British Journal of Haematology (2)
  6. Leukemia Research (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. John Wiley & Sons (4)
  3. Taylor & Francis Group (4)
  4. Nature Publishing Group (3)
  5. American Society of Clinical Oncology (2)
  6. Biomed Central Ltd (2)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
    Journal Article

    Cornetta, K.; Yao, J.; House, K.; Duffy, L.; Adusumilli, P. S.; Beyer, R.; Booth, C.; Brenner, M.; Curran, K.; Grilley, B.; more...
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Review

    Aldoss, I.; Shah, B. D.; Park, J. H.; Muffly, L.; Logan, A. C.; Brown, P.; Stock, W.; Jabbour, E. J.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
    Journal Article

    Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
    Journal Article

    Wudhikarn, K.; King, A. C.; Geyer, M. B.; Roshal, M.; Bernal, Y.; Gyurkocza, B.; Perales, M. A.; Park, J. H.
    Blood Advances (2022)

    Fulltext@MSK | Save